Characterization during storage and dissolution of Solid dispersions containing furosemide and hydroxypropyl methylcellulose

Journal of Drug Delivery Science and Technology

Volumn 23, Issue 4, 2013, Pages 409-415

  Hagner Nielsen, L ^a   Rades, T ^a   Mullertz A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Amorphous fiirosemide; Biorelevant dissolution; Hydroxypropyl methylcellulose; Physical stability; Solid dispersions; Solid state characterisation

Indexed keywords

FUROSEMIDE; HYDROXYPROPYLMETHYLCELLULOSE;

CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); DISPERSION; DISSOLUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; FLOW RATE; HUMIDITY; RAMAN SPECTROMETRY; REVIEW; SPRAY DRYING; STORAGE TEMPERATURE;

EID: 84881607103     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(13)50058-X     Document Type: Review

References (36)

1. Martin A. - Physical Pharmacy, Physical Chemical Principles in the Pharmaceutical Sciences. - Williams&Wilkins, Baltimore, 1993.
2. Hancock B. C., Zografi G. - Characteristics and significance of the amorphous state in pharmaceutical systems - J. Pharm. Sci., 86, 1-12, 1997.
3. Bates S., Zografi G., Engers D., Morris K., Crowley K., Newman A. - Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns - Pharm. Res., 23, 2333-2349, 2006. (Pubitemid 44515011)
4. Lobmann K., Laitinen R., Grohganz H., Gordon K. C., Strachan C., Rades T. - Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen - Mol. Pharm., 8, 1919-1928, 2011.
5. Nielsen L. H., Keller S. S., Gordon K. C., Boisen A., Rades T., Mullertz A. - Spatial confinement can lead to increased stability of amorphous indomethacin - Eur. J. Pharm. Biopharm., 81, 418-425, 2012.
6. Bhugra C., Pikal M. J. - Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state - J. Pharm. Sci., 97, 1329-1349, 2008.
7. Taylor L. S., Zografi G. - Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions - Pharm. Res., 14, 1691-1698, 1997. (Pubitemid 28062912)
8. Law D., Schmitt E. A., Marsh K. C., Everitt E. A., Wang W., Fort J. J., Krill S. L., Qiu Y. - Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations - J. Pharm. Sci., 93, 563-570, 2004. (Pubitemid 38332289)
9. Vasconcelos T., Sarmento B., Costa P. - Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs - Drug Discov. Today, 12, 1068-1075, 2007. (Pubitemid 350186132)
10. Patterson J. E., James M. B., Forster A. H., Lancaster R. W., Butler J. M., Rades T. - The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds - J. Pharm. Sci., 94, 1998-2012, 2005. (Pubitemid 41551483)
11. Qian F., Huang J., Hussain M. A. - Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development - J. Pharm. Sci., 99, 2941-2947, 2010.
12. Chieng N., Rades T., Saville D. - Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling - Eur. J. Pharm. Biopharm., 68, 771-780, 2008. (Pubitemid 351318218)
13. Miller J. M., Beig A., Carr R. A., Spence J. K., Dahan A. - Awinwin solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability - Mol. Pharm., 9, 2009-2016, 2012.
14. Chiou W. L., Riegelman S. - Pharmaceuticalapplicationsofsolid dispersion systems - J. Pharm. Sci., 60, 1281-1302, 1971.
15. Matsumoto T., Zografi G. - Physical properties of solid molecular dispersions of indomethacin with poly (vinylpyrrolidone) and poly (vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization - Pharm. Res., 16, 1722-1728, 1999. (Pubitemid 29530405)
16. Crowley K. J., Zografi G. - The effect of low concentrations of molecularly dispersed poly (vinylpyrrolidone) on indomethacin crystallization from the amorphous state - Pharm. Res., 20, 1417-1422, 2003. (Pubitemid 37164050)
17. Leuner C., Dressman J. - Improving drug solubility for oral delivery using solid dispersions - Eur. J. Pharm. Biopharm., 50, 47-60, 2000. (Pubitemid 30326688)
18. Newman A., Engers D., Bates S., Ivanisevic I., Kelly R. C., Zografi G. - Characterization of amorphous API Polymer mixtures using X-ray powder diffraction - J. Pharm. Sci., 97, 4840-4856, 2008.
19. Pajander J., Baldursdottir S., Rantanen J., Ostergaard J. - Behaviour of HPMC compacts investigated using UV-imaging - Int. J. Pharm., 427, 345-353, 2012.
20. Dahan A., Beig A., loffe-Dahan V., Agbaria R., Miller J. M. - The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane - AAPS J, 2012.
21. Kayaert P., Van den Mooter G. - An investigation of the adsorption of hydroxypropylmethyl cellulose 2910 5 mPa s and polyvinylpyrrolidone K90 around Naproxen nanocrystals - J. Pharm. Sci., 101, 3916-3923, 2012.
22. Alonzo D. E., Zhang G. G., Zhou D., Gao Y., Taylor L. S. - Understanding the behavior of amorphous pharmaceutical systems during dissolution - Pharm. Res., 27, 608-618, 2010.
23. Granero G. E., Longhi M. R., Mora M. J., Junginger H. E., Midha K. K., Shah V. P., Stavchansky S., Dressman J. B., Barends D. M. - Biowaiver monographs for immediate release solid oral dosage forms: furosemide - J. Pharm. Sci., 99, 2544-2556, 2010.
24. Amidon G. L., Lennernas H., Shah V. P., Crison J. R. - Atheoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability - Pharm. Res., 12, 413-420, 1995.
25. Goud N. R., Gangavaram S., Suresh K., Pal S., Manjunatha S. G., Nambiar S., Nangia A. - Novel furosemide cocrystals and selection of high solubility drug forms - J. Pharm. Sci., 101, 664-680, 2012.
26. lannucceili V., Coppi G., Leo E., Fontana F., Bernabei M. T. - PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system - Drug Dev. Ind. Pharm., 26, 595-603, 2000. (Pubitemid 30317065)
27. McNamara P. J., Foster T. S., Digenis G. A., Patel R. B., Craig W. A., Welling P. G., Rapaka R. S., Prasad V. K., Shah V. P. - Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study - Pharm. Res., 4, 150-153, 1987. (Pubitemid 17089605)
28. Matsuda Y., Tatsumi E. - Physiochemical characterization of furosemide modifications - Int. J. Pharm., 60, 11-26, 1990.
29. Nielsen L. H., Gordon S., Holm R., Selen A., Rades T., Mullertz A. - Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats - Submitted, 2013.
30. Doherty C., York P. - Mechanisms of dissolution of frusemide/PVP solid dispersions - Int. J. Pharm., 34, 197-205, 1987. (Pubitemid 17227496)
31. Avdeef A., Tsinman O. - Miniaturized rotating disk intrinsic dissolution rate measurement: effects of buffer capacity in comparisons to traditional wood's apparatus - Pharm. Res., 25, 2613-2627, 2008.
32. Noyes A., Whitney W. - The rate of solution of solid substances in their own solutions - J. Am. Chem. Soc., 19, 930-934, 1897.
33. Marsac P. J., Konno H., Taylor L. S. - Acomparison of the physical stability of amorphous felodipine and nifedipine systems - Pharm. Res., 23, 2306-2316, 2006. (Pubitemid 44511511)
34. Weuts I., Kempen D., Verreck G., Decorte A., Heymans K., Peeters J., Brewster M., Van den Mooter G. - Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying - Eur. J. Pharm. Biopharm., 59, 119-126, 2005. (Pubitemid 39573443)
35. Velasco M. V., Ford J. L., Rowe P., Rajabi-Siahboomi A. R. - Influence of drug: hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets - J. Control Release, 57, 75-85, 1999. (Pubitemid 29005075)
36. Savolainen M., Kogermann K., Heinz A., Aaltonen J., Peltonen L., Strachan C., Yliruusi J. - Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy - Eur. J. Pharm. Biopharm., 71, 71-79, 2009.